Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
在接种了含 ISCOMATRIX 佐剂的全长 NY-ESO-1 疫苗的患者中,检测到了免疫优势 CD4+ 反应。
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.0403271101
Chen, Qiyuan; Jackson, Heather; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan; Chen, Weisan